Vimarsana
Biggest News Aggregation in the World

New Clicks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New Clicks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Clicks Today - Breaking & Trending Today

ANTHEA JEFFERY: Procedural defects bar president's assent to expropriation bill - Business Day — Institute of Race Relations - Vimarsana News

ANTHEA JEFFERY: Procedural defects bar president's assent to expropriation bill - Business Day — Institute of Race Relations

The expropriation bill of 2020 was passed by parliament in March and needs only President Cyril Ramaphosa’s assent to become law. However, under section 79 of the constitution the president may not sign a bill into law if he “has reservations about its constitutionality”. Instead, he must refer it “back to the National Assembly for reconsideration”.

Source: irr.org.za
Pharmacists say losing to Clicks would have opened pati... - Vimarsana News

Pharmacists say losing to Clicks would have opened pati...

Pharmacists at Clicks incentivised to prescribe their ‘own’ in-house medication, which was ‘not only unethical, but also a conflict of interest’ — ICPA.

John Hlophe — the Judge President who fought the law, b... - Vimarsana News

John Hlophe — the Judge President who fought the law, b...

The faiths and high hopes that a young Mandlakayise John Hlophe carried from KwaDukuza via Cambridge and finally as Judge President of the Western Cape, appear to underpin the lack of appetite for more than a decade to hold him accountable.

Clicks under attack by independent pharmacists - Vimarsana News

Clicks under attack by independent pharmacists

A case launched by ICPA against the Clicks group six years ago is scheduled for a final round in the Constitutional Court in September.

Bayer vs Clicks in a blood-thinning battle - Vimarsana News

Bayer vs Clicks in a blood-thinning battle

Clicks and Bayer South Africa, the local scion of the German pharmaceutical giant, were at war in the Patent Court last week.